
Amazonian Strain: Origins and History
Amazonian, sometimes sold as Amazon or Amazonian cubensis, is a Psilocybe cubensis strain. The name refers to a reputed origin in the Amazon basin. Several origin stories circulate among growers, but none is backed by a documented collection record, so the Amazon link is best treated as part of the name rather than a verified history.
That is normal for cubensis. A 2025 review notes that most strain names are informal and community-based, and that cultivars sold under the same name by different suppliers are often not genetically similar (Kurzbaum et al., 2025). Two packets labelled “Amazonian” may not contain the same genetics.
What Are Amazonian Mushrooms?
Amazonian mushrooms are the fruiting bodies of Psilocybe cubensis, the same species as Golden Teacher and Penis Envy. They contain psilocybin, which the body converts to psilocin, the compound behind the psychedelic effects (NIDA).
Growers and sellers describe the strain as producing large, dense caps and thick stems, and that matches the stock we carry as Amazonian dried mushrooms. Like any cubensis, it bruises blue where handled, because psilocin oxidises into blue compounds after injury (Lenz et al., 2020).
Earlier versions of this page described “Amazonian mushrooms” as rainforest fungi in general. That was misleading. Here, Amazonian is a cubensis strain name, not a category of wild Amazon mushrooms, and wild fungi should never be picked or eaten on the strength of a name.
Amazonian vs Other Psilocybin Mushroom Strains
Amazonian is one of several cubensis strains named after a region, alongside Mazatapec from Mexico and Burma from Myanmar. It has a reputation as one of the stronger classic strains, a step above Golden Teacher, but that reputation comes from user reports rather than published lab comparisons. Our magic mushroom strains guide sets those reputations in context.
Amazonian Potency and Dosage
No published lab data exists for Amazonian specifically. Controlled research shows why that matters: when 14 cubensis strains were grown under identical conditions, total tryptamine content differed by more than 7.8-fold between strains, and psilocybin varied by 13% to 23% between individual mushrooms of the same strain (Sharchaton et al., 2026). A strong reputation is a reason to start lower, not higher.
Commonly cited harm-reduction reference points for dried cubensis are roughly 0.1 to 0.3 grams for a microdose, 1 to 2.5 grams for a moderate experience, and 3.5 grams or more for a strong one. Our dosage chart and microdosing guide explain how those ranges are used. They are general reference points, not medical advice.
Amazonian Effects and Experience
Psilocybin effects typically appear within 15 to 45 minutes and last four to six hours (Health Canada). Amazonian is commonly described as visual and energetic, but individual reports vary widely. NIDA notes that expectations, setting, dose, potency and biology all shape the experience, which can feel blissful or frightening (NIDA).
Side effects can include raised heart rate and blood pressure, nausea, confusion and anxiety. People with heart conditions, a personal or family history of psychosis, or who take psychiatric medication face higher risks.
How to Take Amazonian Shrooms Safely
Clinical safety guidelines emphasise preparation, a calm and safe environment, screening for a personal or family history of psychosis, and a supportive person present throughout (Johnson et al., 2008). For stronger doses, a sober trip sitter is the single most useful precaution.
Weigh doses on a 0.01 g scale and start low with every new batch. Health Canada warns that combining mushrooms with alcohol, cannabis or other drugs raises the risk of serious side effects (Health Canada). Never drive while the effects last.
Amazonian Mushrooms: Legal Status in Canada
Psilocybin and psilocin are controlled substances in Canada. Health Canada states that the production, sale and possession of magic mushrooms are illegal unless authorised, for example through an approved clinical trial, a section 56 exemption, or a practitioner’s request through the Special Access Program, which has accepted psilocybin requests since 2022. Municipal non-enforcement policies do not change federal law. If you are unsure about your own situation, check current Health Canada guidance or get independent legal advice.
FAQ
Do Amazonian mushrooms really come from the Amazon?
The name claims an Amazon origin, but no documented collection record exists. Treat it as part of the strain name rather than a verified history.
Is Amazonian stronger than Golden Teacher?
It has that reputation, but no published lab data compares the two, and batch-to-batch variation is often larger than the difference between strains.
What do Amazonian mushrooms look like?
Growers describe large, dense caramel-brown caps with thick stems that bruise blue when handled, typical of a robust cubensis.
Are Amazonian mushrooms the same as wild rainforest mushrooms?
No. Amazonian is a cultivated Psilocybe cubensis strain. Wild mushrooms should never be picked or eaten based on a name.
Related reading: Compare all magic mushroom strains · Mazatapec strain guide · Burma strain guide
References
- Kurzbaum E, Páleníček T, Sharchaton A, et al. Exploring Psilocybe cubensis strains: cultivation techniques, psychoactive compounds, genetics and research gaps. Journal of Fungi. 2025;11(2):99. doi:10.3390/jof11020099
- Sharchaton A, Parsha S, Azerrad SP, et al. Surprising variability in tryptamine profiles of Psilocybe cubensis fruiting bodies: inter- and intra-strain differences across 14 strains cultivated under controlled conditions. Journal of Fungi. 2026;12(7):486. doi:10.3390/jof12070486
- Lenz C, Wick J, Braga D, et al. Injury-triggered blueing reactions of Psilocybe “magic” mushrooms. Angewandte Chemie International Edition. 2020;59(4):1450–1454. doi:10.1002/anie.201910175
- National Institute on Drug Abuse. Psilocybin (magic mushrooms).
- Health Canada. Psilocybin and psilocin (magic mushrooms).
- Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology. 2008;22(6):603–620. doi:10.1177/0269881108093587